Investors of Revvity (RVTY) have enjoyed a 53% gain over the last five years. Their upcoming Earnings Call is scheduled for November 4, 2024. However, notable share transactions have occurred recently with both Squarepoint Ops LLC and Artemis Investment Management LLP selling their holdings. Insiders have also reportedly sold over 4,300 shares. Despite these transactions, both the demand for Revvity's Diagnostic Products and sales continue to propel profits. Several analysts question if the company is undervalued, while others suggest that affordable entry might be challenging. Notably, Artemis Investment Management LLP sold their stake, and Handelsbanken Fonder AB increased theirs. Additionally, MBB Public Markets I LLC invested $908,000 in Revvity. Finally, Revvity is seeking Injunctive Relief Against Cloud Software Group, and the Pomerantz Law Firm is investigating claims on behalf of its investors.
Revvity RVTY News Analytics from Thu, 08 Sep 2011 07:00:00 GMT to Fri, 11 Oct 2024 07:35:33 GMT - Rating 1 - Innovation 3 - Information 8 - Rumor -5
